Olfactory, gustatory and trigeminal changes in non-hospitalized COVID-19 patients: an exploratory prospective cohort study.

Publication date: Jun 21, 2025

Objectives This study aimed to longitudinally assess the prevalence and characteristics of olfactory, gustatory, and trigeminal changes, and the impact of these changes on daily life and quality of life (QoL) in non-hospitalized COVID-19 patients. Methods Three weeks after confirmed COVID-19 diagnosis, non-hospitalized adult participants enrolled in the COVID HOME study consented to complete a questionnaire by phone on the presence, characteristics, and impact on daily life and QoL of olfactory, gustatory and/or trigeminal changes. Participants reporting taste and/or smell changes completed the same questionnaire at three months and, when still present, at six months. Results The questionnaire was completed by 94/117 participants included in this study three weeks after COVID-19 diagnosis. The 43 participants with smell and/or taste changes completed the questionnaire at three months, and 19 at six months. Of the 94 participants, 56% were female and the median age was 43 [IQR 29-55] years. At three weeks post-infection, olfactory, gustatory, and trigeminal changes were reported by 40 (43%), 37 (39%), and 8 (9%) participants, respectively. During follow-up, olfactory, gustatory, and trigeminal changes were reported by 17 (40%), 14 (33%), and 3 (7%) at three months, and 12 (63%), 9 (47%), and 1 (5%) participants at six months, respectively. Most patients reported an impact of sensory changes on daily life and QoL, mostly describing it as ‘a bit’ or ‘quite a bit’. However, impact did not differ between time points and most participants reported taking no action to cope with these changes. Participants with reported sensory alterations were most interested in professional help at six months. Conclusions In non-hospitalized COVID-19 patients, the reported prevalence of olfactory, gustatory and trigeminal changes is higher three weeks after infection. Most patients report modest impact on daily life and QoL due to these sensory changes, and a subgroup reported a profound effect.

PDF

Concepts Keywords
Cooking Covid
Ibm Doi
June Gustatory
Swedish Https
Vaccinations1415 Medrxiv
Months
Olfactory
Org
Participants
Preprint
Reported
Taste
Trigeminal
Weeks

Semantics

Type Source Name
disease MESH COVID-19
disease IDO quality
disease MESH infection
disease MESH long COVID
disease IDO symptom
disease MESH syndrome
disease MESH dyspnea
disease MESH chest pain
disease IDO facility
drug DRUGBANK Methionine
disease IDO history
disease MESH anosmia
disease MESH ageusia
disease MESH metallic taste
drug DRUGBANK Iron
disease MESH tumors
drug DRUGBANK Tromethamine
disease MESH olfactory impairment
disease MESH severe acute respiratory syndrome
disease MESH Allergy
drug DRUGBANK Pentaerythritol tetranitrate
disease MESH gastrointestinal stromal tumors
drug DRUGBANK Acetaminophen

Download Document

(Visited 2 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *